Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2007
07/26/2007WO2007083893A1 Cell surface expression vector of white spot syndrome virus antigen and microorganism transformed with the same
07/26/2007WO2007083806A1 HEPATITIS C VIRUS 2a-DERIVED HLA-A2-RESTRICTED ANTIGEN PEPTIDE
07/26/2007WO2007083789A1 A method for producing an l-amino acid using a bacterium of enterobacteriaceae family with attenuated expression of the yfeh gene
07/26/2007WO2007083766A1 Method for detecting nucleic acid sequence using intramolecular probe
07/26/2007WO2007083759A1 Bone destruction inhibitor comprising anti-ccl20 antibody
07/26/2007WO2007083693A1 Pyrophosphoric acid sensor and snp typing sensor utilizing the same
07/26/2007WO2007083644A1 Novel protein expression system
07/26/2007WO2007083611A1 Spontaneous pulmonary hypertension model animal, method for production of the model animal, pharmaceutical composition for pulmonary hypertension, and therapeutic method for pulmonary hypertension
07/26/2007WO2007083388A1 Reaction vessel and method of dna amplification reaction
07/26/2007WO2007083274A1 Subsantially pure dermatan sulfate epimerase
07/26/2007WO2007083246A2 Vegf variants
07/26/2007WO2007083226A2 Method for selecting a peptide or polypeptide which binds to a target molecule
07/26/2007WO2007083175A1 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith
07/26/2007WO2007082777A1 C-terminal exon 5.4 of runx1/aml1
07/26/2007WO2007082359A1 Luciferase from macrolampis sp
07/26/2007WO2007065957A3 Methods for generating antigen-specific effector t cells
07/26/2007WO2007065438A3 Detection of foetal cells from maternal blood
07/26/2007WO2007063289A3 Transgenic plant overexpressing a bhlh transcription factor
07/26/2007WO2007063160A3 Alzheimer's disease animal model, method for obtaining same and uses thereof
07/26/2007WO2007062936A3 Dna binding site of a transcriptional activator useful in gene expression
07/26/2007WO2007058833A3 Dof (dna binding with one finger) sequences and methods of use
07/26/2007WO2007056441A3 Binding polypeptides with diversified and consensus vh/vl hypervariable sequences
07/26/2007WO2007056304A3 Mutated forms of ny-eso-1 produced in yeast and uses thereof
07/26/2007WO2007054441A3 Use of armadillo repeat (arm1) polynucleotides for obtaining pathogen resistance in plants
07/26/2007WO2007053637A3 A tumor susceptible rat with a mutation in apc gene
07/26/2007WO2007051271A3 Construction of recombinant adenovirus with genes that codify for sag1, sag2 and sag3
07/26/2007WO2007048780A3 Nucleic acid molecules encoding phosphatidate cytidylyl-transferase-like polypeptides and methods of use
07/26/2007WO2007046087A3 Pharmaceutical compositions and diagnostic methods for inflammatory skin disesaes, disorders or conditions
07/26/2007WO2007039507A3 Methods of identifying antibodies to ligands of orphan receptors
07/26/2007WO2007039317A3 Plants having an increased content of amino sugars
07/26/2007WO2007030008A3 Ruvx holliday junction resolvase genes and methods of use
07/26/2007WO2007026310A3 Improved stress tolerance in plants
07/26/2007WO2007022369A3 Chemically modified short interfering nucleic acid molecules that mediate rna interference
07/26/2007WO2007019616A3 Modification of endophyte infection
07/26/2007WO2007018442A3 Expression of an active carrier for xylose in genetically modified saccharomyces cerevisiae
07/26/2007WO2007015268B1 Antiporter gene from porteresia coarctata for conferring stress tolerance
07/26/2007WO2007010133A3 Polypeptides having an activity in the mtbe degradation path and uses thereof
07/26/2007WO2007008309A3 Stem and progenitor cell expansion by evi, evi-like genes and setbp1
07/26/2007WO2007004104A3 Transformed plants accumulating mono- and/or sesquiterpenes
07/26/2007WO2007002031A3 Dna polymerase blends and mutant dna polymerases
07/26/2007WO2006138430A3 Mig-6 knockout mice and elucidation of association of mig- 6 with early onset degenerative joint disease and role as a tumor suppressor
07/26/2007WO2006136579A3 Expression cassettes for seed-preferential expression in plants
07/26/2007WO2006133312A3 Ordered multi-step synthesis by nucleic acid-mediated chemistry
07/26/2007WO2006132788A3 Transgenic models for different genes and their use for gene characterization
07/26/2007WO2006130527A3 Mutations and polymorphisms of fibroblast growth factor receptor 1
07/26/2007WO2006125678A3 Reversible male-sterile plants
07/26/2007WO2006113743A3 Compositions and methods for rna interference with sialidase expression and uses thereof
07/26/2007WO2006110677A3 Gene inactivated mutants with altered protein production
07/26/2007WO2006102461A3 Influenza therapeutic
07/26/2007WO2006083331A3 Use of rna trans-splicing for antibody gene transfer and antibody polypeptide production
07/26/2007WO2006078262A3 Methods of activation during nuclear transfer
07/26/2007WO2006071804A3 Anti-il-12 antibody based vectors, host cells, and methods of production and uses
07/26/2007WO2006071746A3 Engineered dopamine neurons and uses thereof
07/26/2007WO2006069036A3 Anti-il-12 antibodies, epitopes, compositions, methods and uses
07/26/2007WO2006024041A3 Monomeric and dimeric fluorescent protein variants and methods for making same
07/26/2007WO2006017577A3 Nucleic acids encoding anthelmintic agents and plants made therefrom
07/26/2007WO2005051998A3 Antibodies binding to a c-terminal fragment of apolipoprotein e
07/26/2007WO2005041857A3 Bone morphogenetic protein (bmp) 2a and uses thereof
07/26/2007WO2004098530A3 Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
07/26/2007WO2004091515A3 iRNA CONJUGATES
07/26/2007WO2004003175A3 Process and materials for production of glucosamine and n-acetylglucosamine
07/26/2007WO2003081210A3 Identification of kinase inhibitors
07/26/2007WO2003068908A8 Cardiotoxin molecular toxicology modeling
07/26/2007WO2003062448A3 Sqv nucleic acids and polypeptides
07/26/2007WO2003053220A3 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
07/26/2007WO2002038600A9 C. elegans genes involved in viability and/or reproduction and uses thereof
07/26/2007US20070174938 Corn root preferential promoters and uses thereof
07/26/2007US20070174937 Plant having tolerance to environmental stress
07/26/2007US20070174936 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
07/26/2007US20070174935 For regulating expression of heterologous nucleotide sequences in plants; transforming a plant cell to comprise a heterologous nucleotide sequence operably linked to one or more of the regulatory sequences and regenerating a stably transformed plant from the transformed plant cell
07/26/2007US20070174934 Method of selectively producing male or female sterile plants
07/26/2007US20070174933 Altering levels of anti-nutrient factors in plants
07/26/2007US20070174932 High amylose potato polysaccharide for use as renewable raw materials in food processing
07/26/2007US20070174931 Methods for controlling gibberellin levels
07/26/2007US20070174930 Soybean cultivar s050238
07/26/2007US20070174929 Seeds produced by crossing soybean cultivar 5726085 with itself or with another soybean variety; insect resistance, herbicide resistance, disease resistance
07/26/2007US20070174928 Soybean cultivar 5830261
07/26/2007US20070174927 Transgenic expression constructs for vegetative plant tissue specific expression of nucleic acids
07/26/2007US20070174926 Sperm factor oscillogenin
07/26/2007US20070174924 Transgenic mice containing TRP gene disruptions
07/26/2007US20070174922 Nucleic acid encoding novel type-1 cytokine receptor glm-r
07/26/2007US20070173889 Methods and apparatus for conversion of eukaryotic cells by application of electric and magnetic fields
07/26/2007US20070173545 Activation of hypoxia-inducible gene expression
07/26/2007US20070173476 Exposing double stranded polynucleotide comprised of a sense strand and an antisense strand to target nucleic acid and wherein at least one strand comprises at least one orthoester modified nucleotide; medical diagnosis; genetic engineering
07/26/2007US20070173475 Double strand compositions comprising differentially modified strands for use in gene modulation
07/26/2007US20070173474 Double strand compositions comprising differentially modified strands for use in gene modulation
07/26/2007US20070173470 Methods for delivering extracellular target into cells
07/26/2007US20070173457 Tau-conotoxin peptides
07/26/2007US20070173443 polypeptides that induce apoptosis of cancer cells that contain mutant p53 or over-expressed wild-type p53
07/26/2007US20070173431 Novel variant hypocrea jercorina CBH1 cellulases
07/26/2007US20070172950 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use of gene transfer
07/26/2007US20070172949 For use in systems for delivering and expressing desired genes and gene sequences; genetic engineering; gene therapy
07/26/2007US20070172948 Double strand compositions comprising differentially modified strands for use in gene modulation
07/26/2007US20070172946 Lineage specific cells and progenitor cells
07/26/2007US20070172937 Recombinant cells that highly express chromosomally-integrated heterologous genes
07/26/2007US20070172936 Purified active HCV NS2/3 protease
07/26/2007US20070172933 Thermally stable amidases
07/26/2007US20070172932 L-Glutamic Acid-Producing Microorganism and a Method for Producing L-Glutamic Acid
07/26/2007US20070172922 Secretion, transcription and sporulation genes in Bacillus clausii
07/26/2007US20070172921 Secretion, transcription and sporulation genes in Bacillus clausii